Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

High Incidence of Synchronous or Metachronous Breast Cancer in Patients with Malignant and Benign Thyroid Tumor or Tumor-like Disorders

YOSHINORI NIO, CHIKAGE IGUCHI, MASAYUKI ITAKURA, TOMOKO TOGA, KOJI HASHIMOTO, MAKOTO KOIKE, HIROSHI OMORI, YOSHITOSHI SATO and SHIN-ICHIRO ENDO
Anticancer Research May 2009, 29 (5) 1607-1610;
YOSHINORI NIO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nio{at}star.ocn.ne.jp
CHIKAGE IGUCHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAYUKI ITAKURA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOKO TOGA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOJI HASHIMOTO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAKOTO KOIKE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROSHI OMORI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHITOSHI SATO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHIN-ICHIRO ENDO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Incidence time of breast cancer before and after thyroid surgery. Among 33 breast cancers, 17 were coincident with thyroid diseases, 15 proceded to thyroid surgery, and only one was after thyroid surgery. The mean period between the breast cancer surgery and the thyroid surgery was 3.2 years for overall: 3.9 years for thyroid cancer; 3.7 years for adenoma; and 2.3 years for adenomatous goiter.

Tables

  • Figures
  • Table I.
  • Table II.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 29, Issue 5
May 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
  • Back Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
High Incidence of Synchronous or Metachronous Breast Cancer in Patients with Malignant and Benign Thyroid Tumor or Tumor-like Disorders
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
High Incidence of Synchronous or Metachronous Breast Cancer in Patients with Malignant and Benign Thyroid Tumor or Tumor-like Disorders
YOSHINORI NIO, CHIKAGE IGUCHI, MASAYUKI ITAKURA, TOMOKO TOGA, KOJI HASHIMOTO, MAKOTO KOIKE, HIROSHI OMORI, YOSHITOSHI SATO, SHIN-ICHIRO ENDO
Anticancer Research May 2009, 29 (5) 1607-1610;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
High Incidence of Synchronous or Metachronous Breast Cancer in Patients with Malignant and Benign Thyroid Tumor or Tumor-like Disorders
YOSHINORI NIO, CHIKAGE IGUCHI, MASAYUKI ITAKURA, TOMOKO TOGA, KOJI HASHIMOTO, MAKOTO KOIKE, HIROSHI OMORI, YOSHITOSHI SATO, SHIN-ICHIRO ENDO
Anticancer Research May 2009, 29 (5) 1607-1610;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Follicular Thyroid Carcinoma with Unusual Radioiodine-Refractory Breast Metastasis Mimicking Primary Breast Malignancy
  • Google Scholar

More in this TOC Section

  • Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort
  • Unfavorable Outcomes of T3N0 Remnant Gastric Cancer After Distal Gastrectomy
  • Circulating Tumor DNA Methylation Level Is a More Accurate Prognostic Biomarker in Colon Cancer
Show more Clinical Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire